ECDC Expert meeting on non-pharmaceutical countermeasures for Pandemic flu
The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Expert consultation on the evidence base of public health use of antivirals for prevention and treatment of influenza
Neuraminidase inhibitors, commonly referred to as antivirals, have been subject to much debate about the effectiveness in preventing and treating influenza. ECDC convened a meeting of experts in order to review and discuss evidence regarding antivirals.
New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published
This evaluated patients admitted to hospital with laboratory-confirmed or clinically diagnosed influenza A H1N1pdm09 virus infection.
Development of public health programmes for prevention and control of seasonal influenzaArchived
ECDC training programme workshop on “Development of public health programmes for prevention and control of seasonal influenza” took place in Stockholm 8-10 October 2012.